Bokf Na Purchases 3,997 Shares of MetLife, Inc. (NYSE:MET)

Bokf Na increased its holdings in MetLife, Inc. (NYSE:MET) by 117.8% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,389 shares of the financial services provider’s stock after purchasing an additional 3,997 shares during the period. Bokf Na’s holdings in MetLife were worth $519,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of MET. Forum Financial Management LP boosted its holdings in shares of MetLife by 1.0% in the 2nd quarter. Forum Financial Management LP now owns 13,729 shares of the financial services provider’s stock worth $964,000 after purchasing an additional 141 shares during the period. Drive Wealth Management LLC increased its position in MetLife by 3.5% during the second quarter. Drive Wealth Management LLC now owns 4,217 shares of the financial services provider’s stock valued at $296,000 after acquiring an additional 141 shares during the last quarter. Hills Bank & Trust Co raised its stake in shares of MetLife by 8.3% in the second quarter. Hills Bank & Trust Co now owns 1,855 shares of the financial services provider’s stock valued at $130,000 after acquiring an additional 142 shares during the period. CNB Bank lifted its holdings in shares of MetLife by 9.3% in the 1st quarter. CNB Bank now owns 1,735 shares of the financial services provider’s stock worth $129,000 after acquiring an additional 147 shares during the last quarter. Finally, Marcum Wealth LLC boosted its stake in shares of MetLife by 4.7% during the 1st quarter. Marcum Wealth LLC now owns 3,436 shares of the financial services provider’s stock worth $255,000 after purchasing an additional 153 shares during the period. Hedge funds and other institutional investors own 89.81% of the company’s stock.

MetLife Stock Performance

Shares of MET stock opened at $77.38 on Tuesday. The firm has a market cap of $55.03 billion, a price-to-earnings ratio of 26.59, a PEG ratio of 0.61 and a beta of 1.04. MetLife, Inc. has a 52-week low of $57.91 and a 52-week high of $79.34. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.56. The company’s 50 day moving average is $74.02 and its 200 day moving average is $72.37.

MetLife (NYSE:MET) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $2.28 EPS for the quarter, topping the consensus estimate of $2.13 by $0.15. MetLife had a return on equity of 21.41% and a net margin of 4.23%. The firm had revenue of $17.82 billion during the quarter, compared to analyst estimates of $18.57 billion. During the same period in the previous year, the company posted $1.94 EPS. The business’s revenue for the quarter was up 7.2% compared to the same quarter last year. On average, sell-side analysts anticipate that MetLife, Inc. will post 8.67 EPS for the current fiscal year.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 10th. Stockholders of record on Tuesday, August 6th were issued a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.82%. The ex-dividend date of this dividend was Tuesday, August 6th. MetLife’s dividend payout ratio is currently 74.91%.

Analysts Set New Price Targets

A number of research firms recently weighed in on MET. Keefe, Bruyette & Woods reduced their price objective on shares of MetLife from $86.00 to $85.00 and set an “outperform” rating on the stock in a research report on Monday, July 8th. Citigroup boosted their price objective on MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a report on Tuesday, July 23rd. Bank of America reduced their target price on MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a research note on Tuesday, September 10th. Finally, JPMorgan Chase & Co. raised their price target on shares of MetLife from $81.00 to $86.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 2nd. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $84.54.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.